1. European Organisation for Rare Diseases (EURORDIS). Rare diseases: understanding this public health priority. Paris: European Organisation for Rare Diseases; 2005. Available at
https://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf
. Accessed 12 Sep 2018
2. Field M, Boat T. Institute of medicine (us) committee on accelerating rare diseases research and orphan product development. Rare diseases and orphan products: accelerating research and development; 2010.
3. NHISS. The statistics of national heatlh insurance: population with health insurance coverage.
http://nhiss.nhis.or.kr/bd/ad/bdada013cv.do
. Accessed 13 Jan 2018.
4. Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119(7):964–79.
5. Commission of the European Communities. Communication from the commission to the council, the european parliament, the european economic and social committee, and the committee of the regions: on rare diseases: Europe’s challenges. 2008.